🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 31572Q881
- Market Cap
- Large Cap
- IPO
- 11/13/2014 · $18.00/share
Business: FibroGen, Inc. is a leading science-based biopharmaceutical company discovering and developing a pipeline of first-in-class therapeutics. The company applies its pioneering expertise in fibrosis and hypoxia-inducible factor (HIF) biology and clinical development to advance innovative medicines for the treatment of anemia, fibrotic disease, and cancer.
Notes: AUTO-CRE
Company Contact
- CEO
- Thane Wettig
- CFO
- Juan Graham
- Headquarters
- 409 Illinois Street, San Francisco, CA 94158
- Phone
- 415-978-1200
- Fax
- 415-978-1902
- Investor Relations
- Michael Tung · 415-978-1433 · ir@fibrogen.com